Skip to main content

Pfizer, BioNTech will ask FDA to authorize COVID booster for healthy kids ages 5-11

Pfizer and BioNTech said Tuesday that they would ask the Food and Drug Administration (FDA) to authorize a booster dose of their coronavirus vaccine for emergency use in healthy kids ages 5 to 11.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.